The multipotency property of mesenchymal stem cells (MSCs) has attained worldwide
consideration because of their immense potential for immunomodulation and their …

Current treatment modalities are not effective in halting the progression of most CKD. Renal
fibrosis is a pathological process common to all CKD and thereby represents an excellent …

Background In this study, we tested the hypothesis that a combined adipose-derived
mesenchymal stem cell (ADMSC) and ADMSC-derived exosome therapy protected rat …

Chronic kidney disease (CKD) is an important health concern that is expected to be the fifth
most widespread cause of death worldwide by 2040. The presence of chronic inflammation …

Most hypertensive cases are primary and heavily associated with modifiable risk factors like
salt intake. Evidence suggests that even small reductions in salt consumption reduce blood …

Ischemia/reperfusion injury (IRI) represents a worldwide public health issue of increasing
incidence. IRI may virtually affect all organs and tissues and is associated with significant …

This study tested the hypothesis that healthy adipose-derived mesenchymal stem cell
(ADMSC)-derived exosomes (HMSC EXO) and apoptotic (A)(induced by 12 h hypoxia/12 h …

Acute kidney injury (AKI) is a major renal disease associated with high mortality rate and
increasing prevalence. Decades of research have suggested numerous chemical and …

Sepsis-induced lung injury is a clinical syndrome characterized by injury of alveolar
epithelium cells (AECs). Previous investigations illustrate that exosomes secreted from …

Introduction: Transplantation of autologous mesenchymal stem cells (MSCs) has been
shown to attenuate renal injury and dysfunction in several animal models, and its efficacy is …